Epoch 12: Deal Flow & Dough
Capital Markets & Transactions, Trading Strategies, Emerging MOAs in Inflammation & Obesity
Welcome to the 63 NEW Biotech Innovators who have joined us this month! If you haven’t subscribed, join the 1,722 researchers, investors, operators, academics, clinicians and entrepreneurs by subscribing here:
Hello Avatar! Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on the general market update. For…
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.